Novartis Investigative Site

Frederiksberg DK-2000

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Chronic Heart Failure, Psoriatic Arthritis, Spondylitis, Ankylosing, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early